Cargando…
Present status and future perspective of peptide‐based vaccine therapy for urological cancer
Use of peptide‐based vaccines as therapeutics aims to elicit immune responses through antigenic epitopes derived from tumor antigens. Peptide‐based vaccines are easily synthesized and lack significant side‐effects when given in vivo. Peptide‐based vaccine therapy against several cancers including ur...
Autores principales: | Obara, Wataru, Kanehira, Mitsugu, Katagiri, Toyomasa, Kato, Renpei, Kato, Yoichiro, Takata, Ryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834812/ https://www.ncbi.nlm.nih.gov/pubmed/29345737 http://dx.doi.org/10.1111/cas.13506 |
Ejemplares similares
-
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma
por: Obara, Wataru, et al.
Publicado: (2016) -
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma
por: Kato, Renpei, et al.
Publicado: (2017) -
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study
por: Takata, Ryo, et al.
Publicado: (2021) -
A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer
por: Kato, Yoichiro, et al.
Publicado: (2018) -
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer
por: Obara, Wataru, et al.
Publicado: (2017)